Primary Care Corner with Geoffrey Modest MD: fenofibrate,not so effective

There was extended followup of ACCORD-Lipid study for 5 years after the study ended, which confirmed the original conclusions that adding fenofibrate to simvastatin in diabetic patients did not improve cardiovascular outcomes, and that the assessment of prespecified outcomes also found that the subgroup with low HDL/high triglycerides did better with fenofibrate, but women overall did worse (see doi:10.1001/jamacardio.2016.4828 )   Details: –4644 […]

Read More…